What is the 13F Pro Quality Score for NUTX?

13F Pro ranks Nutex Health Inc. (NUTX) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NUTX's current score at https://13fpro.ai/company/NUTX (free sign-up required for the full ranking).

Which hedge funds own the most NUTX stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of NUTX include Pertento Partners LLP, BlackRock,, AMERICAN CENTURY COMPANIES. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/NUTX as soon as new 13F filings post.

Where does 13F Pro source NUTX data?

All Nutex Health Inc. fundamentals and ownership data come directly from SEC EDGAR. Nutex Health Inc. files with the SEC under CIK 1479681. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NUTX in?

Nutex Health Inc. (NUTX) is classified in the Industrials sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/industrials.

What drives NUTX's revenue?

Per Nutex Health Inc.'s latest 10-Q filed with the SEC on 2026-08-06, the biggest revenue drivers are: Hospital division ($201.9M, -14.6% YoY); Population health management division ($8.9M); Insurance (96% of transaction price). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/NUTX.

What are NUTX's largest expenses?

Nutex Health Inc.'s latest 10-Q reports these as the largest expense items: Payroll ($42.8M); General and administrative expenses ($16.7M, +$4.2M YoY); Stock-based compensation ($2.9M, -$75.9M YoY). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended June 30, 2026).

How often is NUTX research updated on 13F Pro?

NUTX's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Nutex Health Inc.(NUTX)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Industrials →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1479681 NUTX stock profile & AI dashboard →

13F Pro Quality Score

74.1/100

Rank #121 of 2,961 stocksTOP 5%

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

95.8/100

Profitability

85.3/100

Balance Sheet

96.0/100

Earnings Quality

58.4/100

Free Cash Flow

85.7/100

Institutional Flow

55.1/100

Revenue Scale

47.1/100

Dilution Risk

14.1/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why NUTX Scores 74/100

exact factor attribution · 2026-09-11

NUTX's composite is driven by revenue growth and free cash flow, held back by shareholder dilution. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+9.2 pts

96th pct

Free cash flow

+5.4 pts

86th pct

Profitability

+5.3 pts

85th pct

Capital efficiency

+4.6 pts

96th pct

Earnings growth

+0.9 pts

67th pct

Earnings quality

+0.8 pts

58th pct

Institutional flow

+0.3 pts

55th pct

Scale

-0.4 pts

47th pct

Shareholder dilution

-1.8 pts

14th pct

Latest change (2026-08-06): 74 → 68 · ↓ Capital efficiency 89→76; ↓ Free cash flow 84→71

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

NUTX Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Nutex Health Inc. (NUTX), a Industrials sector company. 13F Pro's AI-powered ranking engine scores NUTX at 74.1/100 on a 32-signal composite quality model, placing it at rank #121 of 2,961 stocks — the top 5% of the AI-ranked universe. NUTX scores in the top quartile across balance sheet strength (96.0), revenue growth (95.8), free cash flow (85.7). Shareholder dilution risk is elevated at 14.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Nutex Health Inc. reports quarterly revenue of $210.8M, net income of $65.8M, free cash flow of $31.7M. Top institutional holders of NUTX by reported 13-F value include Pertento Partners LLP, BlackRock, AMERICAN CENTURY COMPANIES, based on the most recent SEC filings. NUTX trades on the Nasdaq exchange and files with the SEC under CIK 1479681. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NUTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nutex Health Inc. directly from SEC EDGAR. Nutex Health Inc.'s 13F Pro composite quality score has ranged between 21 and 80 since 2022, currently 74.1 — a stable long-term trajectory across 62 quarterly and live scoring snapshots.

✦

Fun facts about Nutex Health Inc.

Quirks, history, and lore behind NUTX — the kind of stuff that makes a stock memorable.

1
The Basics
A small-cap U.S. company operating in the healthcare facilities space, listed on Nasdaq, and headquartered in Texas.
2
The Numbers
Revenue in the hundreds of millions of dollars, but like many facility operators it has wrestled with thin or negative margins as it works through a growth-heavy build-out phase.
3
The History
Built through acquisition and development of hospital facilities, the company went public via a SPAC merger — the fashionable way to list in the early 2020s.
4
The Secret
Its core business model centers on owning and operating micro-hospitals — small, full-service inpatient facilities designed to serve suburban and underserved communities that big hospital systems ignore.
5
The Lore
The company also has a hospital management division that partners with health systems, effectively letting it collect fees for running other people's hospitals too — a tidy side hustle.
6
The Giveaway
Think tiny hospitals, big ambitions — this Houston-based operator of micro-hospitals across multiple states trades under a ticker that neatly rhymes with "bucks."

▶ Think you know your stocks? Play the Daily Ticker

What's Driving NUTX's Business? Latest 10-Q Breakdown

✓ 31/31 datapoints verified

AI-extracted from Nutex Health Inc.'s 10-Q filed 2026-08-06 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenue fell to $210.8M as hospital division revenue dropped 14.6% YoY, but a $52.3M reduction to contract services expense from the HaloMD amendment and CMS fee cut lifted net income to $96.3M.

Biggest Revenue Drivers

Hospital division$201.9M-14.6% YoY

Decrease primarily attributed to positive adjustments to variable consideration realized in 2025 as the Company experienced early success with the IDR process.

Population health management division$8.9M

Increase from $7.7M primarily due to increased members.

Biggest Revenue Drivers

Total revenue: $210.8M

Hospital division$201.9M-14.6% YoY

Decrease primarily attributed to positive adjustments to variable consideration realized in 2025 as the Company experienced early success with the IDR process.

Within Hospital division

Insurance96% of transaction price

Allocation of estimated transaction price by primary patient insurance classification; 97% in the prior-year quarter.

Self-pay2% of transaction price

Copays, deductibles and self-payment; 1% in the prior-year quarter.

Population health management division$8.9M

Increase from $7.7M primarily due to increased members.

Largest Expense Items

Payroll$42.8M

Up from $36.3M; higher payroll driven by increased wages to the physician LLCs, bonus payments and other payroll and benefits expenses.

General and administrative expenses$16.7M+$4.2M YoY

Includes executive management, accounting, human resources, corporate technology, insurance and professional fees.

Stock-based compensation$2.9M-$75.9M YoY

Lower expense on obligations for under-construction and ramping hospitals versus $78.7M in the prior-year quarter.

Contract services$1.1M

Down from $61.1M; reflects a $52.3M reduction from the HaloMD pay-on-collected amendment ($38.4M), revised service fee structure ($9.6M) and CMS fee cut ($4.3M).

Margins: Consolidated gross profit rose to $141.3M from $124.9M; hospital division gross profit increased 13.0% to $141.8M, primarily driven by lower total cost of arbitration of $(12.5)M versus $48.0M last year.

Watch Items from the Filing

The $52.3M contract services reduction was a change in estimate that increased net income by $43.0M and diluted EPS by $3.64 basic/$3.56 diluted this quarter.
Hospital revenue fell 14.6% and same-hospital revenue fell 12.1% even as patient visits rose 9.6%, reflecting prior-year IDR variable-consideration adjustments.
Company operates out-of-network with no negotiated rates; 96% of transaction price comes from insurance, and IDR estimation is highly subjective and volatile.
Pending securities class action and consolidated derivative suits seek unspecified damages; the Company cannot estimate potential financial impact.
Approximately 256,005 shares remain disputed by former doctor owners, including ABQ's 216,039 shares; trial is set for September 21, 2026.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$210.8M

Net Income

Q2 2026

$65.8M

Free Cash Flow

Q2 2026

$31.7M

D/E Ratio

Q2 2026

0.10

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+82.4% YoY

$875.3MFY 2025

FY22 $219.3MFY23 $247.6MFY24 $479.9MFY25 $875.3M

Net Income

+35.9% YoY

$70.8MFY 2025

FY22 $-424.8MFY23 $-45.8MFY24 $52.1MFY25 $70.8M

Operating Income

+110.9% YoY

$275.6MFY 2025

FY22 $-406.6MFY23 $-31.8MFY24 $130.7MFY25 $275.6M

EPS (Diluted)

+8.2% YoY

$10.48FY 2025

FY22 $-1.50FY23 $-0.16FY24 $9.69FY25 $10.48

Total Assets

+40.2% YoY

$918.5MFY 2025

FY22 $431.8MFY23 $398.2MFY24 $655.3MFY25 $918.5M

Total Debt

+15.3% YoY

$42.5MFY 2025

FY22 $35.6MFY23 $37.1MFY24 $36.9MFY25 $42.5M

Op. Cash Flow

+971.6% YoY

$248.1MFY 2025

FY22 $50.6MFY23 $1.3MFY24 $23.2MFY25 $248.1M

Free Cash Flow

+1077.9% YoY

$245.6MFY 2025

FY22 $36.0MFY23 $-8.2MFY24 $20.8MFY25 $245.6M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$875.3M +82.4%	$479.9M +93.8%	$247.6M +12.9%	$219.3M -33.9%	$331.5M +21.0%	$274.0M
Net Income	$70.8M +35.9%	$52.1M +213.8%	$-45.8M +89.2%	$-424.8M -420.4%	$132.6M +25.1%	$106.0M
Operating Income	$275.6M +110.9%	$130.7M +511.3%	$-31.8M +92.2%	$-406.6M -338.8%	$170.3M +11.2%	$153.2M
EPS (Diluted)	$10.48 +8.2%	$9.69 +6347.6%	$-0.16 +89.6%	$-1.50 -45490.9%	$0.00 +22.2%	$0.00
Total Assets	$918.5M +40.2%	$655.3M +64.6%	$398.2M -7.8%	$431.8M +9.4%	$394.7M +232242.5%	$169.9K
Total Debt	$42.5M +15.3%	$36.9M -0.7%	$37.1M +4.3%	$35.6M -80.0%	$178.3M	$0.00
Operating Cash Flow	$248.1M +971.6%	$23.2M +1742.8%	$1.3M -97.5%	$50.6M -70.8%	$173.4M +100.1%	$86.7M
Free Cash Flow	$245.6M +1077.9%	$20.8M +353.0%	$-8.2M -122.9%	$36.0M -73.6%	$136.5M +435.7%	$25.5M

Get alerted when NUTX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Nutex Health Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NUTX

Pertento Partners LLP
$77.1M451,310 sh
BlackRock, Inc.
$69.6M407,349 sh
AMERICAN CENTURY COMPANIES INC
$40.6M237,414 sh
VANGUARD CAPITAL MANAGEMENT LLC
$36.9M215,919 sh
GEODE CAPITAL MANAGEMENT, LLC
$22.6M132,049 sh
STATE STREET CORP
$22.4M130,836 sh
D. E. Shaw & Co., Inc.
$16.7M97,454 sh
UBS Group AG
$13.3M77,912 sh
WINMILL & CO. INC
$11.2M65,350 sh
Focus Partners Wealth
$10.4M60,881 sh

Fund	Value	Shares
Pertento Partners LLP	$77.1M	451,310
BlackRock, Inc.	$69.6M	407,349
AMERICAN CENTURY COMPANIES INC	$40.6M	237,414
VANGUARD CAPITAL MANAGEMENT LLC	$36.9M	215,919
GEODE CAPITAL MANAGEMENT, LLC	$22.6M	132,049
STATE STREET CORP	$22.4M	130,836
D. E. Shaw & Co., Inc.	$16.7M	97,454
UBS Group AG	$13.3M	77,912
WINMILL & CO. INC	$11.2M	65,350
Focus Partners Wealth	$10.4M	60,881

Companies Similar to NUTX

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

RELY

Remitly Global, Inc.

AI score

Similar quality profile · 1 shared holders

SIERRA SUMMIT ADVISORS LLC

LPG

DORIAN LPG LTD.

AI score

Similar quality profile · 1 shared holders

Cambria Investment Management, L.P.

CART

Maplebear Inc.

AI score

Similar quality profile · 2 shared holders

Cambria Investment Management, L.P.JUPITER ASSET MANAGEMENT LTD

PAYS

Paysign, Inc.

AI score

Similar quality profile · 1 shared holders

Topline Capital Management, LLC

GNTX

GENTEX CORP

AI score

Similar quality profile

AER

AerCap Holdings N.V.

AI score

Similar quality profile

INSW

International Seaways, Inc.

AI score

Similar quality profile · 3 shared holders

SummerHaven Investment Management, LLC Cambria Investment Management, L.P.MACQUARIE GROUP LTD

ATRO

ASTRONICS CORP

AI score

Similar quality profile · 2 shared holders

Pertento Partners LLP JUPITER ASSET MANAGEMENT LTD

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Industrials Companies

View all Industrials →

AADX

Applied Aerospace & Defense, Inc.

AAL

American Airlines Group Inc.

AAON

AAON, INC.

ABM

ABM INDUSTRIES INC /DE/

ACA

Arcosa, Inc.

ACHR

Archer Aviation Inc.

ACLS

AXCELIS TECHNOLOGIES INC

ACMR

ACM Research, Inc.

Put NUTX on your watchlist

Track score changes the day Nutex Health Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NUTX a good stock to buy?

13F Pro's AI-powered analysis of Nutex Health Inc. (NUTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NUTX are available on the NUTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NUTX is classified as a small company.

Which hedge funds own NUTX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NUTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Nutex Health Inc.'s investment landscape.